SMITTY TONY: Open Payments
NPI 1386240620 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $421
Food & beverage: $251Education: $170
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $134 |
| Janssen Biotech, Inc. | 2 | $133 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| GlaxoSmithKline, LLC. | 1 | $32 |
| SOBI, INC | 1 | $31 |
| Syndax Pharmaceuticals, Inc. | 1 | $31 |
| Incyte Corporation | 1 | $28 |
Products named: DARZALEX, PREVYMIS, Xospata, OJJAARA, Vonjo, Cresemba, JAKAFI.
Industry payments across TX — which companies pay providers there.
